ALEMBIC LIMITED (ALEMBICLTD) financials
ALEMBIC LIMITED (ALEMBICLTD) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.With its registered…
- Market Cap: ₹2,496Cr.
- Current Price: ₹97.4
- Stock P/E: 20.4
- ROE: 14.2%
- ROCE: 16.9%
- Book Value: ₹32.0
- Dividend Yield: 2.47%
- 52W High / Low: ₹118/70.5
In Jun 2026, ALEMBIC LIMITED (ALEMBICLTD) reported sales ₹46 Cr and net profit ₹15 Cr.
Annual TTM: sales ₹230 Cr, net profit ₹122 Cr.
Shareholding: Promoters 71.40% (Sep 2026), FIIs 1.34% (Sep 2026), DIIs 0.05% (Sep 2026), Public 27.20% (Sep 2026), No. of Shareholders 1,00,706% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 51 | 56 | 58 | 48 | 54 | 72 | 58 | 46 |
| Expenses | 33 | 30 | 32 | 29 | 32 | 45 | 38 | 32 |
| Operating Profit | 18 | 26 | 26 | 19 | 23 | 27 | 20 | 14 |
| OPM % | 36% | 46% | 45% | 39% | 42% | 37% | 34% | 30% |
| Other Income | 66 | 4 | 3 | 3 | 65 | 2 | 2 | 6 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 81 | 27 | 26 | 19 | 84 | 25 | 18 | 16 |
| Tax % | 5% | 4% | 11% | 10% | 10% | 12% | 48% | 7% |
| Net Profit | 77 | 26 | 23 | 17 | 76 | 22 | 10 | 15 |
| EPS in Rs | 2.98 | 1.00 | 0.89 | 0.67 | 2.95 | 0.87 | 0.37 | 0.57 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 74 | 72 | 76 | 123 | 152 | 214 | 232 | 230 |
| Expenses | 70 | 62 | 63 | 85 | 96 | 125 | 144 | 147 |
| Operating Profit | 4 | 11 | 13 | 38 | 56 | 90 | 88 | 83 |
| OPM % | 5% | 15% | 17% | 31% | 37% | 42% | 38% | 36% |
| Other Income | 93 | 10 | 89 | 54 | 55 | 75 | 73 | 75 |
| Interest | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 |
| Depreciation | 3 | 4 | 4 | 6 | 7 | 10 | 12 | 13 |
| Profit before tax | 94 | 17 | 97 | 85 | 103 | 152 | 147 | 144 |
| Tax % | 0% | 19% | 12% | 7% | 10% | 7% | 15% | — |
| Net Profit | 94 | 13 | 86 | 79 | 93 | 142 | 125 | 122 |
| EPS in Rs | 3.64 | 0.52 | 3.34 | 3.09 | 3.62 | 5.53 | 4.85 | 4.76 |
| Dividend Payout % | 16% | 38% | 54% | 71% | 66% | 43% | 49% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
| Reserves | 361 | 432 | 775 | 962 | 778 | 757 | 802 | 770 |
| Borrowings | -0 | -0 | 0 | -0 | -0 | 9 | 14 | 11 |
| Other Liabilities | 57 | 51 | 109 | 130 | 119 | 128 | 142 | 126 |
| Total Liabilities | 470 | 534 | 936 | 1,144 | 948 | 946 | 1,010 | 958 |
| Fixed Assets | 209 | 225 | 261 | 294 | 318 | 366 | 406 | 470 |
| CWIP | -0 | 3 | 6 | 0 | 0 | 1 | -0 | 2 |
| Investments | 205 | 197 | 581 | 726 | 503 | 411 | 414 | 349 |
| Other Assets | 55 | 109 | 88 | 124 | 127 | 168 | 190 | 138 |
| Total Assets | 470 | 534 | 936 | 1,144 | 948 | 946 | 1,010 | 958 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 22 | 5 | -1 | -22 | 35 | 25 | 81 | 117 |
| Cash from Investing Activity | 68 | 57 | -35 | 23 | 11 | 23 | -22 | -52 |
| Cash from Financing Activity | -89 | -6 | -15 | -6 | -46 | -48 | -58 | -67 |
| Net Cash Flow | 1 | 56 | -52 | -5 | -0 | 0 | 2 | -1 |
| Free Cash Flow | -1 | -16 | -44 | -55 | 10 | -31 | 30 | 41 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 145% | 187% | 8% | -102% | 108% | 42% | 107% | 156% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 70.88% | 71.40% |
| FIIs | 1.78% | 1.65% | 1.50% | 1.38% | 1.29% | 1.25% | 1.25% | 1.34% |
| DIIs | 0.06% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.06% | 0.05% |
| Public | 27.27% | 27.41% | 27.57% | 27.68% | 27.78% | 27.81% | 27.82% | 27.20% |
| No. of Shareholders | 1,07,423 | 1,06,732 | 1,07,510 | 1,06,470 | 1,04,103 | 1,02,008 | 1,01,238 | 1,00,706 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40 | 44 | 66 | 72 | 67 | 42 | 47 | 48 |
| Inventory Days | 289 | 411 | 2,112 | 2,885 | 5,118 | 3,694 | — | 1,161 |
| Days Payable | 202 | 151 | 675 | 635 | 993 | 1,213 | — | 510 |
| Cash Conversion Cycle | 126 | 304 | 1,504 | 2,322 | 4,191 | 2,523 | 47 | 698 |
| Working Capital Days | 13 | 28 | 96 | 231 | 127 | 75 | 58 | -2 |
| ROCE % | 10% | 21% | 2% | 10% | 10% | 12% | 18% | 17% |
Alembic Limited
₹2,496Cr.
₹97.4
₹118/70.5
20.4
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of ALEMBIC LIMITED (ALEMBICLTD)?
The reported market capitalisation for ALEMBIC LIMITED (ALEMBICLTD) is ₹2,496Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of ALEMBICLTD?
The current price shown for ALEMBIC LIMITED (ALEMBICLTD) on Fincrux is ₹97.4 with a 52-week high/low of ₹118/70.5.
What is the P/E ratio of ALEMBIC LIMITED (ALEMBICLTD)?
The stock P/E for ALEMBIC LIMITED (ALEMBICLTD) is 20.4 on Fincrux, with ROE at 14.2% and ROCE at 16.9%.
What were ALEMBICLTD latest quarterly results?
For Jun 2026, ALEMBIC LIMITED (ALEMBICLTD) reported sales ₹46 Cr and net profit ₹15 Cr (figures in ₹ crore unless noted).
What are ALEMBICLTD annual sales and net profit?
For TTM, ALEMBIC LIMITED (ALEMBICLTD) shows sales of ₹230 Cr and net profit of ₹122 Cr on the Fincrux profit & loss statement.
Who owns ALEMBIC LIMITED (ALEMBICLTD)?
Latest shareholding for ALEMBIC LIMITED (ALEMBICLTD) on Fincrux: Promoters 71.40% (Sep 2026), FIIs 1.34% (Sep 2026), DIIs 0.05% (Sep 2026), Public 27.20% (Sep 2026), No. of Shareholders 1,00,706% (Sep 2026).
Where can I find ALEMBIC LIMITED (ALEMBICLTD) financials?
ALEMBIC LIMITED (ALEMBICLTD) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show ALEMBICLTD balance sheet and cash flow?
Yes. The ALEMBIC LIMITED (ALEMBICLTD) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.